Edition:
India

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

0.43USD
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
$0.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
157,267
52-wk High
$2.07
52-wk Low
$0.41

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $36.10
Shares Outstanding(Mil.): 74.69
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates